Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Fintech PR

Newmark Launches Paris Office, Bolstering Global Expansion with Key Talent Additions




NEW YORK and PARIS, March 11, 2024 /PRNewswire/ — Newmark Group, Inc. (Nasdaq: NMRK) (“Newmark”), a leading commercial real estate advisor and service provider to large institutional investors, global corporations, and other owners and occupiers, announces it has established a Paris, France flagship, hiring industry veterans Francois Blin and Emmanuel Frénot to lead the team. As the latest milestone in Newmark’s continued global expansion, the Paris office, which officially opens today, March 11, 2024, will initially focus on Capital Markets and Leasing and is located at 32 Boulevard Haussmann 75009 Paris in the 9th arrondissement, home to some of Paris’ most iconic landmarks, including the Opera Garnier and the famous Grands Magasins. Reinforcing Newmark’s reputation for industry-leading talent, the launch of the Paris office has attracted several of Paris’ top commercial real estate professionals to debut its market foothold:

  • Francois Blin and Emmanuel Frénot join from JLL and CBRE as Chief Business Officer and Deputy Chief Business Officer, respectively, to lead the Paris team and to focus on Capital Markets.
  • Antoine Salmon and Vianney d’Ersu, Co-Heads Retail Leasing, join from Knight Frank to spearhead Retail operations. Additionally, retail specialists Sarah Aghion, Alexandre Lechat, Louis Combet and Clara Leclerc will join to work alongside Salmon and d’Ersu.
  • Jérôme De Laboulaye, Managing Director, joins from CBRE Capital Markets France to contribute to and build Newmark’s Capital Markets Office practice.
  • Nicolas Coutant will join from JLL to contribute to and assist in building various business lines.
  • David Bourla, Head of Research, joins from Knight Frank to head all French research initiatives at Newmark, providing data-driven market insights and high-end economic analysis and surveys in support of clients and brokerage professionals.
  • Alexandre Gotti, Newmark’s President of France, will oversee operations, strategic direction, growth and recruiting, assisting in developing Newmark’s footprint in France and Europe.

“Newmark continues to broaden its reach and evolve with the industry’s demands and our clients’ needs, and our expansion into France with the amalgamation of such an impressive team is a significant milestone in our growth strategy and presents yet another opportunity to generate outstanding results,” said Chief Executive Officer Barry Gosin. “We look forward to continuing to grow our European footprint and attracting top talent across the globe as we further increase revenues across our diverse geographies and service lines.”

Bringing more than a half-century of combined experience, these top hires will establish a robust and fully operational presence in the French market underpinned by market-leading research and Newmark’s global services and reach across multiple sectors. Newmark expects the addition of this team to bolster its ability to provide best-in-class service to clients around the world who seek to diversify their investments by geography and property type.

“If you are exceptional, Newmark is where you belong. Our continued expansion in the European market is driven by our commitment to excellence for our clients. Our goal is to establish ourselves as the go-to market leader in France, built by industry market-makers,” continued Gosin. “The Company is bridging the gap between major financial cities, uniting undeniable talent from major real estate markets around the world, including New York, Los Angeles, London, and now Paris. As we continue to onboard talented professionals in these and other locations, we have unwavering confidence in Newmark’s future.”

As a major European financial and economic center, Paris attracts a wide range of domestic and international businesses and investors seeking long-term value and stability. The city’s strategic location, excellent infrastructure, diverse range of commercial real estate opportunities and strong connectivity make it an attractive destination for local, regional and global companies. France has consistently maintained its status as a prime real estate market, with a recent surge in demand for logistics and warehousing spaces, and in Paris, residential and office assets in prime locations. Overall, the market is expected to rebound as economic conditions gradually improve.

As the commercial real estate firm with the best long-term growth rate in the industryi, Newmark continues to invest in elevating its platform’s capabilities and infrastructure, underpinned by the recruitment and retention of industry-leading talent across geographies and verticals within the real estate spectrum, strategic leadership appointments in leasing, capital markets and multifamily and entrances into new sectors throughout 2023. Additionally, with the recent hires of Matthew Featherstone and Jonathan Firestone to lead Debt and Structured Finance in the UK and US, respectively, Newmark continues to prioritize its unification strategy to build a comprehensive platform of owner/occupier services globally.

About Newmark
Newmark Group, Inc. (Nasdaq: NMRK), together with its subsidiaries (“Newmark”), is a world leader in commercial real estate, seamlessly powering every phase of the property life cycle. Newmark’s comprehensive suite of services and products is uniquely tailored to each client, from owners to occupiers, investors to founders, and startups to blue-chip companies. Combining the platform’s global reach with market intelligence in both established and emerging property markets, Newmark provides superior service to clients across the industry spectrum. For the year ending December 31, 2023, Newmark generated revenues of approximately $2.5 billion. Newmark’s company-owned offices, together with its business partners, operated from approximately 170 offices with 7,400 professionals around the world. To learn more, visit or follow @newmark

Discussion of Forward-Looking Statements about Newmark
Statements in this document regarding Newmark that are not historical facts are “forward-looking statements” that involve risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements. These include statements about the Company’s business, results, financial position, liquidity, and outlook, which may constitute forward-looking statements and are subject to the risk that the actual impact may differ, possibly materially, from what is currently expected. Except as required by law, Newmark undertakes no obligation to update any forward-looking statements. For a discussion of additional risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements, see Newmark’s Securities and Exchange Commission filings, including, but not limited to, the risk factors and Special Note on Forward-Looking Information set forth in these filings and any updates to such risk factors and Special Note on Forward-Looking Information contained in subsequent reports on Form 10-K, Form 10-Q or Form 8-K.

i Newmark generated faster revenue growth than any of its publicly traded competitors from 2011 to 2022, the last fiscal year for which data is available for the entire group. Newmark’s 2011 revenues are based on unaudited full year 2011 revenues for Newmark & Company Real Estate, Inc., (“Newmark & Co.”) while 2012 is based on the Real Estate Services segment of the Company’s former parent, BGC Partners, Inc. (“BGC”), which acquired Newmark & Co. in 2011, IPOed the Company in 2017, and spun Newmark off in 2018. The peers included in the 2011-2022 average are US tickers CBRE, CIGI, JLL, MMI, and WD, and UK ticker symbol SVS (in GBP). These companies generated total revenue CAGRs of between 7% and 21% from 2011 through 2022, or a simple average of 15%. Only some of these peers reported fee revenues during this timeframe. In addition, US ticker CWK did not report revenues for periods before 2015 and is therefore excluded. For some years, the impact of FASB topic ASC 606 increased GAAP revenues for Newmark and certain peers.

Newmark Group, Inc.

Photo –
Logo – 

Cision View original content:

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Fintech PR

Invitation to presentation of EQT AB’s Q1 Announcement 2024




STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.

The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.

To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.

The webcast can be followed live here and a recording will be available afterwards.

Information on EQT AB’s financial reporting

The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.

The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.

Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]

Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334

This information was brought to you by Cision,c3956826

The following files are available for download:

Invitation to presentation of EQT AB’s Q1 Announcement 2024,c3285895

EQT AB Group


View original content:

Continue Reading

Fintech PR

Kia presents roadmap to lead global electrification era through EVs, HEVs and PBVs



  • Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
  • Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
  • Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
    • Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
    • PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
  • Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
  • 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
  • CEO reaffirms Kia’s commitment to ESG management

SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.

Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.

During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.

The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.

“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”

Photo –

Cision View original content to download multimedia:

Continue Reading

Fintech PR

BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update




VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.

As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.

The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.

Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.

About BioVaxys Technology Corp.

BioVaxys Technology Corp. (, a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit and connect with us on X and LinkedIn.


Signed “James Passin
James Passin, Chief Executive Officer
Phone: +1 646 452 7054

Logo –

Cision View original content:

Continue Reading